My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 110

    1.

    Anti-VEGF for neovascular ARMD: visual improvement as the goal of therapy?

    Bopp S.

    Br J Ophthalmol. 2007 Oct;91(10):1259-60. No abstract available. PMID: 17895411 [PubMed - indexed for MEDLINE]Related articles

    2.

    [Treatment of neovascular age-related macular degeneration with bevacizumab]

    Monzón Moreno A.

    Farm Hosp. 2006 Nov-Dec;30(6):387-8. Spanish. No abstract available. PMID: 17298199 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.

    Ciulla TA, Rosenfeld PJ.

    Curr Opin Ophthalmol. 2009 May;20(3):158-65. Review.PMID: 19417570 [PubMed - indexed for MEDLINE]Related articles

    4.

    [Monitoring of AMD patients on anti-vascular endothelial growth factor (VEGF) treatment. Practical notes on functional and anatomical examination parameters from drug approval studies, specialist information and case series]

    Meyer CH, Helb HM, Eter N.

    Ophthalmologe. 2008 Feb;105(2):125-38, 140-2. Review. German. PMID: 18256841 [PubMed - indexed for MEDLINE]Related articles

    5.

    Development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

    Ferrara N, Damico L, Shams N, Lowman H, Kim R.

    Retina. 2006 Oct;26(8):859-70. Review.PMID: 17031284 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Anti-VEGF treatment for retinal angiomatous proliferation]

    Wolf A, Kook D, Kreutzer T, Gandorfer A, Haritoglou C, Kampik A, Ulbig M.

    Ophthalmologe. 2008 Sep;105(9):845-51. German. PMID: 18607601 [PubMed - indexed for MEDLINE]Related articles

    7.

    Promising new treatments for neovascular age-related macular degeneration.

    Michels S, Schmidt-Erfurth U, Rosenfeld PJ.

    Expert Opin Investig Drugs. 2006 Jul;15(7):779-93. Review.PMID: 16787141 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.

    Kourlas H, Abrams P.

    Clin Ther. 2007 Sep;29(9):1850-61. Review.PMID: 18035187 [PubMed - indexed for MEDLINE]Related articles

    9.

    Controversies in the treatment of wet age-related macular degeneration.

    Moreno SF, Paloma JB.

    Am J Ophthalmol. 2008 May;145(5):937; author reply 938. No abstract available. PMID: 18435977 [PubMed - indexed for MEDLINE]Related articles

    10.

    The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.

    Hussain N, Ghanekar Y, Kaur I.

    Indian J Ophthalmol. 2007 Nov-Dec;55(6):445-50. Review.PMID: 17951902 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Re: development of ranibizumab, an anti-vascular endothelial growth factor antigen binding fragment, as therapy for neovascular age-related macular degeneration.

    Ziemssen F, Heiduschka P, Schraermeyer U; Tübingen Bevacizumab Study Group.

    Retina. 2007 Oct;27(8):1154-6; author reply 1156-8. No abstract available. PMID: 18040264 [PubMed - indexed for MEDLINE]Related articles

    12.

    Anti-VEGF therapy: riding the wave of change.

    Hunyor AP.

    Clin Experiment Ophthalmol. 2008 Jul;36(5):401-2. No abstract available. PMID: 18925912 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Treatment of neovascular age-related macular degeneration with Ranibizumab/Lucentis]

    Michels S, Rosenfeld PJ.

    Klin Monbl Augenheilkd. 2005 Jun;222(6):480-4. Review. German. PMID: 15973626 [PubMed - indexed for MEDLINE]Related articles

    14.

    Debate on the various anti-vascular endothelial growth factor drugs.

    Khalili MR, Hosseini H.

    Indian J Ophthalmol. 2008 May-Jun;56(3):255-6; author reply 256. No abstract available. PMID: 18417837 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

    Ng EW, Adamis AP.

    Can J Ophthalmol. 2005 Jun;40(3):352-68. Review.PMID: 15947805 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    [New drug treatment for age-related macular degeneration]

    Stefánsson E, la Cour M, Helgadóttir G, Sigurdsson H, Jónasson F.

    Laeknabladid. 2007 Apr;93(4):299-301. Icelandic. PMID: 17460341 [PubMed - indexed for MEDLINE]Related articles

    17.

    Antiangiogenic therapy in neovascular age-related macular degeneration.

    Lin RC, Rosenfeld PJ.

    Int Ophthalmol Clin. 2007 Winter;47(1):117-37. Review. No abstract available. PMID: 17237677 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anti-vascular endothelial growth factor therapy for ocular neovascular disease.

    Andreoli CM, Miller JW.

    Curr Opin Ophthalmol. 2007 Nov;18(6):502-8. Review.PMID: 18163003 [PubMed - indexed for MEDLINE]Related articles

    19.

    Safety and efficacy of intravitreal anti-VEGF injections for age-related macular degeneration.

    Jeganathan VS, Verma N.

    Curr Opin Ophthalmol. 2009 May;20(3):223-5. Review.PMID: 19367163 [PubMed - indexed for MEDLINE]Related articles

    20.

    Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration: a short-term study.

    Chen CY, Wong TY, Heriot WJ.

    Am J Ophthalmol. 2007 Mar;143(3):510-2. Epub 2006 Nov 13.PMID: 17317398 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity